Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Jones

Showing results (301-310 of 363) with videos related to

Pageof 37
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 8, 2021
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New ZealandJess Howell, Avik Majumdar, Michael A Fink, et al.
Nature|December 6, 2019
c-Jun overexpression in CAR T cells induces exhaustion resistanceRachel C Lynn, Evan W Weber, Elena Sotillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancerM Dror Michaelson, Stephane Oudard, Yen-Chuan Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based therapy: ELM-PC 5Karim Fizazi, Robert Jones, Stephane Oudard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 22, 2024
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensusThomas A Harding, Richard M Martin, Samuel Wd Merriel, et al.
Neuro-Oncology|January 5, 2022
Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urineMélanie Pagès, Denisse Rotem, Gregory Gydush, et al.
European Urology Focus|February 11, 2019
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted TherapyPeter E Hall, Scott T C Shepherd, Janet Brown, et al.
Journal for Immunotherapy of Cancer|May 27, 2025
Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus studyLajos Pusztai, Vernon K Sondak, Raquel Aguiar-Ibáñez, et al.
Microsystems & Nanoengineering|September 27, 2021
A monolithic single-chip point-of-care platform for metabolomic prostate cancer detectionValerio F Annese, Samadhan B Patil, Chunxiao Hu, et al.
BMJ Open|November 29, 2023
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocolMark A Hull, Pei Loo Ow, Sharon Ruddock, et al.
Pageof 37

Showing results (301-310 of 363) with videos related to

Sort By:
Pageof 37
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 8, 2021
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New ZealandJess Howell, Avik Majumdar, Michael A Fink, et al.
Nature|December 6, 2019
c-Jun overexpression in CAR T cells induces exhaustion resistanceRachel C Lynn, Evan W Weber, Elena Sotillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancerM Dror Michaelson, Stephane Oudard, Yen-Chuan Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2015
Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based therapy: ELM-PC 5Karim Fizazi, Robert Jones, Stephane Oudard, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 22, 2024
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensusThomas A Harding, Richard M Martin, Samuel Wd Merriel, et al.
Neuro-Oncology|January 5, 2022
Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urineMélanie Pagès, Denisse Rotem, Gregory Gydush, et al.
European Urology Focus|February 11, 2019
Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted TherapyPeter E Hall, Scott T C Shepherd, Janet Brown, et al.
Journal for Immunotherapy of Cancer|May 27, 2025
Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus studyLajos Pusztai, Vernon K Sondak, Raquel Aguiar-Ibáñez, et al.
Microsystems & Nanoengineering|September 27, 2021
A monolithic single-chip point-of-care platform for metabolomic prostate cancer detectionValerio F Annese, Samadhan B Patil, Chunxiao Hu, et al.
BMJ Open|November 29, 2023
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocolMark A Hull, Pei Loo Ow, Sharon Ruddock, et al.
Pageof 37